EUVIMEDEUVIMED entdecken
Crossref

Ximelagatran as a New Oral Anticoagulant for Thrombosis

Ola E Dahl, Jan Jacques Michiels

Seminars in Vascular Medicine · 01.01.2005 · 5 (03) · 223-225

DOI: 10.1055/s-2005-916160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von Ola E Dahl und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis Research Institute, London, United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAzetidinesBenzylaminesChemical and Drug Induced Liver InjuryClinical Trials as TopicHumansMyocardial InfarctionThrombinThrombosisVitamin KWarfarin

Substanzen

AnticoagulantsAzetidinesBenzylaminesVitamin KximelagatranWarfarinThrombin

Autor:innen und Institutionen

  • Thrombosis Research Institute, London, United Kingdom.

Zitieren

APA

Dahl, O. E., & Michiels, J. J. (2005). Ximelagatran as a New Oral Anticoagulant for Thrombosis. Seminars in Vascular Medicine, 5(03), 223-225. https://doi.org/10.1055/s-2005-916160

Vancouver

Dahl OE, Michiels JJ. Ximelagatran as a New Oral Anticoagulant for Thrombosis. Seminars in Vascular Medicine. 2005;5(03):223-225. doi:10.1055/s-2005-916160

BibTeX
@article{Dahl2005,
  author = {Dahl, Ola E and Michiels, Jan Jacques},
  title = {Ximelagatran as a New Oral Anticoagulant for Thrombosis},
  journal = {Seminars in Vascular Medicine},
  year = {2005},
  volume = {5},
  number = {03},
  pages = {223--225},
  doi = {10.1055/s-2005-916160}
}
Kostenlos starten →